AGL 40.10 Increased By ▲ 0.10 (0.25%)
AIRLINK 130.50 Increased By ▲ 0.97 (0.75%)
BOP 6.80 Increased By ▲ 0.12 (1.8%)
CNERGY 4.65 Increased By ▲ 0.02 (0.43%)
DCL 9.02 Increased By ▲ 0.08 (0.89%)
DFML 43.40 Increased By ▲ 1.71 (4.1%)
DGKC 84.01 Increased By ▲ 0.24 (0.29%)
FCCL 33.03 Increased By ▲ 0.26 (0.79%)
FFBL 76.75 Increased By ▲ 1.28 (1.7%)
FFL 11.51 Increased By ▲ 0.04 (0.35%)
HUBC 110.55 No Change ▼ 0.00 (0%)
HUMNL 14.82 Increased By ▲ 0.26 (1.79%)
KEL 5.40 Increased By ▲ 0.01 (0.19%)
KOSM 8.22 Decreased By ▼ -0.18 (-2.14%)
MLCF 39.74 Decreased By ▼ -0.05 (-0.13%)
NBP 61.10 Increased By ▲ 0.81 (1.34%)
OGDC 198.40 Decreased By ▼ -1.26 (-0.63%)
PAEL 26.80 Increased By ▲ 0.15 (0.56%)
PIBTL 7.88 Increased By ▲ 0.22 (2.87%)
PPL 158.50 Increased By ▲ 0.58 (0.37%)
PRL 26.50 Decreased By ▼ -0.23 (-0.86%)
PTC 18.50 Increased By ▲ 0.04 (0.22%)
SEARL 82.40 Decreased By ▼ -0.04 (-0.05%)
TELE 8.32 Increased By ▲ 0.01 (0.12%)
TOMCL 34.65 Increased By ▲ 0.14 (0.41%)
TPLP 9.16 Increased By ▲ 0.10 (1.1%)
TREET 17.30 Decreased By ▼ -0.17 (-0.97%)
TRG 61.66 Increased By ▲ 0.34 (0.55%)
UNITY 27.55 Increased By ▲ 0.12 (0.44%)
WTL 1.41 Increased By ▲ 0.03 (2.17%)
BR100 10,478 Increased By 70.9 (0.68%)
BR30 31,811 Increased By 97.4 (0.31%)
KSE100 97,998 Increased By 669.7 (0.69%)
KSE30 30,401 Increased By 208.5 (0.69%)

HYDERABAD, (India): The US Food and Drug Administration (FDA) is gathering information on products of Indian spice makers MDH and Everest after Hong Kong halted sales of some of their products for allegedly containing high levels of a cancer-causing pesticide.

“The FDA is aware of the reports and is gathering additional information about the situation,” an FDA spokesperson told Reuters on Friday.

Hong Kong this month suspended sales of three MDH spice blends and an Everest spice mix for fish curries. Singapore ordered a recall of the Everest spice mix as well, saying it contains high levels of ethylene oxide, which is unfit for human consumption and a cancer risk with long exposure.

Reuters is the first to report the US FDA’s review of alleged contamination of Indian spice products.

MDH and Everest did not immediately respond to Reuters requests for comment on this matter.

Everest has previously said its spices are safe for consumption. MDH has not responded to queries about its products so far.

Comments

Comments are closed.